Market revenue in 2023 | USD 14.3 million |
Market revenue in 2030 | USD 21.7 million |
Growth rate | 6.2% (CAGR from 2023 to 2030) |
Largest segment | Volumetric infusion pumps |
Fastest growing segment | Insulin Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps |
Key market players worldwide | Baxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.
Volumetric infusion pumps was the largest segment with a revenue share of 16.78% in 2023. Horizon Databook has segmented the Singapore intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.
The largest contributors to Singapore’s combined burden of early deaths and disability have been cancer (14.2%) and cardiovascular diseases (13.3%), according to Singapore’s Ministry of Health. As per the National Cancer Centre Singapore, one in every four people may develop cancer, which will be the leading cause of mortality.
This country has the highest Age-standardized Rate (ASR) of cancer in Southeast Asia, leading to increased demand for anticancer treatments. These treatments require precise dosage and are delivered through smart infusion pumps to promote error-free therapy.
This is likely to propel intravenous infusion pumps market in the country. Moreover, Singapore is undertaking many activities for advancements in medical technology by focusing more on R&D and manufacturing innovative & efficient medical devices.
Horizon Databook provides a detailed overview of country-level data and insights on the Singapore intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into Singapore intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account